Booth # 500
CBII.CSE
CB2 Insights has a mission to mainstream medical cannabis into traditional healthcare. We are a research and technology company, offering a suite of data and technology solutions as a full service clinical CRO, specializing in Phase III and Phase IV, post-marketing, observational and experimental trials in a range of therapeutic areas for sponsors worldwide.
Read lessSee CB2 Insights at the Cantech Investment Conference.